Search bioRxiv⌕ Search

Biology subjects

Pahnke, J.

Publications and source records attributed to Pahnke, J..

4 recordsLinked to original sources

MSI-ATLAS: Mass spectrometry imaging and explainable machine learning uncover the brain's lipid landscapes

Recent computational advances in mass spectrometry imaging (MSI) now enable unprecedented insight into organ-wide molecular composition and functional architecture. Here, we present the first high-resolution molecular-computational atlas of specific mouse brain lipids and metabolites, acquired using a NEDC matrix and negative-mode MSI, covering 123 anatomically defined regions and 191 polygonal annotations derived solely from MSI data, without auxiliary imaging. To over-come annotation ambiguity and MSI complexity, we introduced the Computational Brain Lipid Atlas (CBLA), a graph-based visual-explainability framework that generates Virtual Landscape Visualizations (VLVs) of specific lipid distributions across brain substructures. The CBLA integrates dimensionality reduction and ensembles of supervised models to (i) refine annotations, (ii) elucidate interregional relationships, (iii) interpret model behavior, and (iv) formulate biologically testable hypotheses. The CBLA revealed novel lipid distribution patterns, functional integrations, anatomical connections - the brains telephone cables, and region-specific disease signatures - index lipids, including disease networks in the basal ganglia. It further identified index lipids that trace extrapyramidal nuclei and their cortical-brainstem connections, highlighting network-level molecular organization. A new algorithm decomposes annotated regions into precise m/z features and resolves high-resolution m/z values from MSI data, producing a comprehensive high-resolution brain map. It can be applied to any MS measurements, including metabolites, lipids, and peptides. This resource underpins down-stream studies, as exemplified here by characterizing the molecular lipid composition of A{beta} plaques, their spatial arrangement, and their connections with surrounding tissue. For the first time, our data suggest that GM3 accumulation in cortical amyloid plaques may originate from hippocampal structures, consistent with longstanding evidence of disrupted hippocampocortical connectivity; a similar origin may also apply to plaque-associated A{beta} signals in the cortex. More broadly, several selected m/z signals showed putative anatomical origins in specific brain subregions. HighlightsO_LIMass spectrometry imaging (MSI) data were used to generate high-resolution, truthful visualizations for brain-region annotation without additional modalities. C_LIO_LIMSI data were further used to build a computational atlas of annotated brain regions. C_LIO_LIPathological structures reveal both their origins and effects on specific brain networks. C_LIO_LIAnatomical regions and functional networks exhibit distinct lipid/metabolite patterns. C_LIO_LIBrainstem nuclei and white matter exhibit distinct lipid/metabolite compositions, indicating their involvement in pathological networks. C_LIO_LIAtlas-based Virtual Landscape Visualizations (VLVs) enable comparison of region-specific differences across mouse models. C_LIO_LISeveral plaque-associated m/z signals, including GM3-related species, show putative hippocampocortical anatomical origins. C_LIO_LIExtrapyramidal nuclei and their cortical-brainstem connections are characterized by shared index lipids, enabling network-level molecular tracing. C_LI

bioinformatics↗

ABCA7 deficiency exacerbates glutamate excitotoxicity in Alzheimer's disease mice -- a new pharmacological target for Glu-related neurotoxicity

Increasing attention has been directed towards the perturbation of glutamate (Glu) and {gamma}-aminobutyric acid (GABA) homeostasis during the pathogenesis of Alzheimers disease (AD). The prevailing disequilibrium, stemming from hyperactivation of the glutamatergic system, culminates in progressive neuronal impairment and cognitive deterioration. This study aimed to elucidate the contributory role of the ATP-binding cassette transporter A7 (ABCA7), identified as the second most critical genetic determinant in AD, in glutamatergic-associated neurotoxicity. This endeavor sought to advance molecular comprehension of neurological disorders where Glu-GABA neurotransmission represents a pivotal pharmacotherapeutic target. Utilizing multi-omics approaches, we rigorously analyzed four distinct mouse models, both with and without APPtg and ABCA7 expression, to simulate varied pathological and ABCA7-deficient states. Our results revealed amyloid-beta (A{beta}) deposition as a catalyst for surging glutamatergic transmission. Notably, ABCA7 ablation exacerbated glutamatergic-induced neurotoxicity, attributed to diminished enzymatic activity related to neurotransmitter degradation and amplified expression levels of specific neurotransmitter transport proteins and receptor subunits, notably NMDA, AMPA, and GABAA. These findings furnish the first comprehensive description elucidating ABCA7s amplification of neurotoxic effects through modulation of Glu-GABA neurotransmission systems in neurodegenerative contexts, primarily mediated by lipid interaction. The evidence underscores ABCA7s imperative role in shaping future pharmacological strategies aimed at counteracting neurodegeneration precipitated by Glu-mediated neurotoxicity. This research advances the frontier for therapeutic exploration to ameliorate the deleterious neural consequences characteristic of neurodegenerative pathologies. HighlightsO_LIAlterations within the ABCA7 transporter locus constitute the second most significant genetic predisposition factor for Alzheimers disease (AD), subsequent to the influence of the APOE4 allele. C_LIO_LIExcessive stimulation of glutamatergic neurotransmission culminates in excitotoxicity, leading to the gradual demise of neuronal populations due to pathological hyperactivity. C_LIO_LIIn murine models with wild-type genetics, the absence of ABCA7 results in diminished functionality of both the glutamatergic and GABAergic neurotransmitter systems. C_LIO_LIConversely, in mouse models engineered to mimic Alzheimers pathology, deficiency in ABCA7 exacerbates glutamate-induced neurotoxicity. C_LIO_LIDuring amyloid-{beta} accumulation, the absence of ABCA7 correlates with an elevation in specific lipid levels, potentially contributing to neurodegenerative processes. C_LIO_LIFrom a therapeutic standpoint, pharmacological activation of ABCA7 may mitigate the neuronal death associated with glutamate overactivation in individuals afflicted by neurodegenerative disorders. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/666774v2_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1491b86org.highwire.dtl.DTLVardef@ae3bb3org.highwire.dtl.DTLVardef@d1716dorg.highwire.dtl.DTLVardef@6dd7a2_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

MSI-VISUAL: New visualization methods for mass spectrometry imaging and tools for interactive mapping and exploration of m/z values

Mass spectrometry imaging (MSI) produces high-dimensional molecular data, but practical interpretation remains limited by visualizations that incompletely preserve global structure. We present MSI-VISUAL, an open-source framework for interactive MSI analysis that integrates truthful dimensionality-reduction visualizations with region-of-interest selection, statistical comparison, and direct m/z mapping. MSI-VISUAL introduces four visualization strategies: SALO and SPEAR, optimization-based methods designed to improve global structure preservation across distance metrics; and TOP3 and PR3D, lightweight approaches for memory-efficient, rapid visualization of large datasets. Across benchmarks and lipidomics case studies, including mouse brain and kidney pathology examples, the proposed methods outperform commonly used alternatives in our benchmarks, improve detection of subtle tissue differences, and reveal fine molecular-anatomical patterns that support new biological insights. These results establish MSI-VISUAL as a scalable framework for discovery-oriented and diagnostic MSI workflows. TeaserTruthful MSI maps reveal hidden tissue patterns, making complex molecular images easier to explore and understand.

bioinformatics↗

Preserving clusters and correlations: a dimensionality reduction method for exceptionally high global structure preservation

Modern dimensionality reduction (DR) methods, including t-SNE and UMAP, often distort global relationships, limiting the interpretability of embeddings. We introduce two complementary objectives that jointly preserve global geometry and local structure. Landmark Mantel Correlation (LMC) aligns high- and low-dimensional distances with respect to a small set of landmarks, providing an efficient global constraint. Multi-resolution Cluster Supervision (MiCS) promotes local fidelity by encouraging cluster assignments--estimated across multiple resolutions--to remain predictable after projection. Evaluated on 20 biomedical datasets, UMAP+LMC and MiCS+LMC achieve the best overall performance, demonstrating that global and local structure can be optimized simultaneously rather than being inherently conflicting. Our approach consistently outperforms existing methods for global and local structure preservation, yielding more reliable and interpretable visualizations.

bioinformatics↗